The global market for Postpartum Hemorrhage (PPH) Treatment Devices is estimated at US$789.3 Million in 2023 and is projected to reach US$1.1 Billion by 2030, growing at a CAGR of 4.6% from 2023 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.
The growth in the PPH treatment devices market is driven by several factors, including rising global incidence of PPH and the growing awareness about maternal health. Rising complications concerning pregnancy, namely large-sized babies, multiple pregnancies, and inverted uterus are also fueling market growth. Further, increase in other risk factors of PPH, like traumatic uterine and uterine atony, an increase in pregnant women with anemia conditions, and rising awareness concerning PPH risks boost the market growth of postpartum hemorrhage devices. The expanding healthcare infrastructure, especially in emerging economies, has facilitated greater access to these advanced treatment options.
Moreover, government initiatives and funding aimed at reducing maternal mortality rates have bolstered market growth. The demand for minimally invasive and easy-to-use devices that can be employed in a variety of healthcare settings, from tertiary care hospitals to rural clinics, has also spurred innovation in this field. These factors collectively ensure the robust expansion of the market, addressing a critical need in maternal healthcare.
The growth in the PPH treatment devices market is driven by several factors, including rising global incidence of PPH and the growing awareness about maternal health. Rising complications concerning pregnancy, namely large-sized babies, multiple pregnancies, and inverted uterus are also fueling market growth. Further, increase in other risk factors of PPH, like traumatic uterine and uterine atony, an increase in pregnant women with anemia conditions, and rising awareness concerning PPH risks boost the market growth of postpartum hemorrhage devices. The expanding healthcare infrastructure, especially in emerging economies, has facilitated greater access to these advanced treatment options.
Moreover, government initiatives and funding aimed at reducing maternal mortality rates have bolstered market growth. The demand for minimally invasive and easy-to-use devices that can be employed in a variety of healthcare settings, from tertiary care hospitals to rural clinics, has also spurred innovation in this field. These factors collectively ensure the robust expansion of the market, addressing a critical need in maternal healthcare.
Key Insights:
- Market Growth: Understand the significant growth trajectory of the Uterine Balloon Tamponade segment, which is expected to reach US$505.9 Million by 2030 with a CAGR of a 4.3%. The Non-Pneumatic Anti-Shock Garment (NASG) segment is also set to grow at 4.6% CAGR over the analysis period.
- Regional Analysis: Gain insights into the U.S. market, estimated at $278.6 Million in 2023, and China, forecasted to grow at an impressive 6.2% CAGR to reach $146.8 Million by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.
Why You Should Buy This Report:
- Detailed Market Analysis: Access a thorough analysis of the Global Postpartum Hemorrhage (PPH) Treatment Devices Market, covering all major geographic regions and market segments.
- Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
- Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Postpartum Hemorrhage (PPH) Treatment Devices Market.
- Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.
Key Questions Answered:
- How is the Global Postpartum Hemorrhage (PPH) Treatment Devices Market expected to evolve by 2030?
- What are the main drivers and restraints affecting the market?
- Which market segments will grow the most over the forecast period?
- How will market shares for different regions and segments change by 2030?
- Who are the leading players in the market, and what are their prospects?
Report Features:
- Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2023 to 2030.
- In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
- Company Profiles: Coverage of major players such as 3RD Stone Design, Inc., Cook Medical LLC, CooperSurgical, Inc., and more.
- Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.
Select Competitors (Total 26 Featured):
- 3RD Stone Design, Inc.
- Cook Medical LLC
- CooperSurgical, Inc.
- Laborie Medical Technologies Corporation
- Organon & Co.
- Revmedx Inc.
- Sinapi Biomedical
- Teleflex Incorporated
- Utah Medical Products, Inc.
Table of Contents
I. METHODOLOGYII. EXECUTIVE SUMMARY2. FOCUS ON SELECT PLAYERSIII. MARKET ANALYSISSOUTH KOREAREST OF ASIA-PACIFICBRAZILREST OF LATIN AMERICAIV. COMPETITION
1. MARKET OVERVIEW
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
UNITED STATES
CANADA
JAPAN
CHINA
EUROPE
FRANCE
GERMANY
ITALY
UNITED KINGDOM
SPAIN
RUSSIA
REST OF EUROPE
ASIA-PACIFIC
AUSTRALIA
INDIA
LATIN AMERICA
MIDDLE EAST
AFRICA
Companies Mentioned
- 3RD Stone Design, Inc.
- Cook Medical LLC
- CooperSurgical, Inc.
- Laborie Medical Technologies Corporation
- Organon & Co.
- Revmedx Inc.
- Sinapi Biomedical
- Teleflex Incorporated
- Utah Medical Products, Inc.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 207 |
| Published | December 2024 |
| Forecast Period | 2023 - 2030 |
| Estimated Market Value ( USD | $ 789.3 Million |
| Forecasted Market Value ( USD | $ 1100 Million |
| Compound Annual Growth Rate | 4.6% |
| Regions Covered | Global |
| No. of Companies Mentioned | 9 |
